Table 3.
Hazard ratio (95% confidence interval) for 5-year all-cause mortality according to acute kidney disease status in patients with head and neck squamous cell carcinoma who were treated with cisplatin.
| AKD status | No. of deaths | Person-years | Mortalitya | HR (95% CI) | |
|---|---|---|---|---|---|
| Crude Model | Adjusted Model | ||||
| Non-AKD | 620 | 4,097 | 15.1 | 1.00 (Reference) | 1.00 (Reference) |
| AKD | 271 | 1,679 | 16.1 | 1.09 (0.95–1.26) | 1.09 (0.94–1.25) |
The model was adjusted for age, sex, baseline estimated glomerular filtration rate, clinical cancer stage, and Charlson Comorbidity Index score.
a
per 100 person-years.
AKD, acute kidney disease; CI, confidence interval; HR, hazard ratio.